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Abstract
Background: RAS, coded by ras proto-oncogenes, played an important role in signal transmission to regulate cell
growth and differentiation. Host activation of RAS was significant for IFN-sensitive vaccinia virus (delE3L) or
attenuate influenza virus in unallowable cells.
Results: Huamn NRAS gene was activated by mutating in codon 61. Then the activation of NRAS was detected by
western blot in MDCK cells. The delNS1 H5N1 influenza virus with deletion of NS1 eIF4GI binding domain was
weak multiplication in MDCK cells. And the replication of delNS1 virus and expression of IFN-beta and IRF-3 were
detected by Real-time PCR in MDCK cells infected with delNS1 virus. It was found that the delNS1 virus had a
significant increase in MDCK cells when the NRAS was activated, and yet, expression of IRF-3 and IFN-beta were
restrained.
Conclusions: The study demonstrated that activated NRAS played an important part for delNS1 virus replication in
MDCK cells. Activated NRAS might be down-regulating the expression of antiviral cellular factors in delNS1 virus
infected cells.
Background
The RAS family (NRAS, KRAS and HRAS) were mem-
bers of the superfamily of small GTP/GDP-binding pro-
tein. They were known for their diverse intracellular
signaling function in various organisms, such as control-
ling of cell proliferation, growth and apoptosis. Activat-
i n gm u t a t i o ni nR A So c c u r r e di nu pt o3 0 %o fh u m a n
cancers. There were three ways to activate RAS protein:
point mutation in ras gene, great amount expression of
RAS and gene insertion or dislocation [1-3]. It was often
found point mutations of codons 12, 13 or 61 in ras
gene [4,5]. Constitutively active RAS, like the V12 muta-
tion and V61 mutation, was predominantly binding with
GTP, because of lower intrinsic GTPase activity and its
resistance to the GTPase-stimulating activity of RAS-
GAPs [6,7]. Activated RAS displayed oncogenic poten-
tial, being assistances of several downstream effectors
including Raf, phosphatidylinositol 3-kinase and etc
[8,9]. In RAS-transformed cells, activated RAS protein
rendered cells permissive to defected virus, like delNS1
influenza virus (an influenza virus lacking the NS1 open
reading frame), by a mechanism that involved induction
of cellular inhibitor of PKR [10].
The nonstructural protein (NS1) of influenza virus
was an important regulatory protein in virus replication
and multiplication especially preventing host antivirus
action. Previous studies suggested that binding of
dsRNA by the NS1 protein blocked the action of the
interferon (IFN)-inducible dsRNA-dependent protein
kinase (PKR) [11,12]. The eIF4GI binding domain-trun-
cated influenza virus did not efficiently replicate and
was impaired in its ability to inhibit IFN production in
vitro [13].
Previously, the delNS1 influenza virus (an influenza
virus lacking the NS1 open reading frame) selectively
replicated in the NRAS-expressing melanomas and had
tumor-ablative potentials [10]. They reasoned that an
activated ras-signaling pathway and inactivated PKR
might allow replication of the delNS1 virus. In present
study, NRAS was activated through point mutation in
codon 61 (named NRAS (K61)). The replication of
delNS1 virus was higher lever in MDCK transfected
NRAS (K61). But the expression of IFN was inhibited in
cells which had activated NRAS and virus incubating.
Therefore, NRAS (K61) transient expressing in MDCK
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enza virus through inhibiting IFN effect.
Methods
Cell culture and Virus
A549 cells were maintained in F12 medium (SIGMA)
supplemented with 10% FBS. And Madin-Darby canine
kidney (MDCK) cells were in Dulbecco’sm o d i f i e d
Eagle’s medium (DMEM) (Invitrogen) with 10% FBS.
DelNS1 influenza virus (H5N1) with the deletion of NS1
eIF4GI binding domain was described previously [13].
Construction of mutated plasmids
The NRAS ORF gene was amplified from A549 cells.
And then the NRAS gene mutated in codons 61 (Q-K)
by point mutation. PcDNA3.1 (+)-NRAS (K61) was
made by inserting the NRAS.
Plasmid transfections and virus infection
Liposomes (Invitrogen) were mixed with 3 μg DNA. And
then, the transfection of MDCK cells was followed the
manufacturer’s instruction. After 12 h of transfection,
MDCK in 6-well plates were incubated with delNS1 virus
at a multiplicity of infection (MOI) of 0.1 in DMEM with
FBS free at 37°C. One hour later, virus-containing solu-
tions were removed by washing the cells twice with PBS.
Infected cells were incubated in maintain medium with
2% FBS in a CO2 incubator at 37°C. Cell Supernatants
and cells were harvested at 12 h, 24 h and 36 h after
infection for western blot analysis and real time PCR.
Experiments with delNS1 H5N1 virus were conducted in
biosafety level 3+ containment facility.
Apoptosis detection
After 36 h of transfected with NRAS (K61), cells’ apop-
tosis was detected by cell death detection kit (Roche)
following the manufacturer’s instruction.
Western blot analysis
Cells were harvested at 36 hours after transfection of
NRAS (K61). Whole cells were lysed using RIPA buffer
containing the cocktail of protease inhibitors (Roche
Molecular Biology). Total protein was loaded on to
SDS-PAGE and transferred on to nitrocellulose paper.
The blot was incubated with the NRAS-specific mono-
clonal antibody F155 (Santa Cruz Biotechnology) fol-
lowed by matching horseradish peroxidase-conjugated
secondary antibody. Protein bands were visualized by
enhanced chemiluminescence (Thermo).
Real-time quantitative PCR for IFN-beta, IRF-3 and delNS1
virus production
To quantify the expressing levels of IFN-beta, IRF-3 and
the replication of delNS1 influenza virus produced in
NRAS (K61) activated cells infected with the delNS1
influenza viruses, a real-time quantitative PCR assay was
used for IFN-beta, IRF-3 and NP. Total RNA was
extracted from the MDCK cells with the RNA isolation
kit (Qiagen), following the manufacturer’s instruction.
Total RNA (1 μg) was used for the synthesis of the first
strand of cDNA. Reverse transcription (RT) was then
carried out using the AMV Reverse Transcriptase XL kit
(Takara). Real-time quantitative polymerase chain reac-
tion (PCR) was conducted with 1 μl cDNA in a total
volume of 25 μl with the iQ SYBR Green supermix
(Bio-Rad), following the manufacturer’s instruction.
Relative expression values were normalized using a beta-
actin internal control. The following oligonucleotide pri-
mer pairs were examined: beta-actin forward CGAGA-
CATTCAACACCCCAAC, beta-actin reverse AGCC-
AGGTCCAGACGCAAG, IFN-beta forward CGCCGC-
AAGGACAGGATA, IFN-beta reverse ACGGGAGG-
TTCA-CAAGAAGGTT, IRF-3 forward GTTGGT-
AACAGACAAGACCGTGAT, IRF-3 reverse GAGTGT-
CGGCTTCCTTTGATG, NP forward TATTCGTCT-
CAGGGAGC-AAAAGCAGGGTA, and NP reverse
ATATCGTCTCGTATTAGTAGAAACAAG-
GGTATTTTT.
Results
Overexpression of mutated NRAS (K61) in MDCK cells
In order to obtain the activated human NRAS protein,
the NRAS gene open reading frame was amplified from
A549 cells and mutated on the 61 codon. The overex-
pression of the NRAS (K61) was examined in MDCK
cells. The blot was shown that lysine mutation in con-
don 61 activated NRAS (Figure 1). Interestingly, it was
observed great changing of cell morphology and disrupt-
ing of cell-cell adhesion. And apoptosis was not dec-
tected in NRAS (K61) transfected cells (Figure 2).
Figure 1 Expression of NRAS (K61) in MDCK cells.M D C Kc e l l s
were transfected with 3 μg of pCDNA3.1 (+)-NRAS (K61). At 36 h
posttransfection, cells were collected and lysed in SDS-PAGE gel
loading buffer. Protein was detected by Western blotting by using
N-ras-specific monoclonal antibody F155. A clear band could be
seen in the blot.
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multiplication in MDCK cells
MDCK cells were infected by delNS1 virus after 12 h of
transfection with NRAS (K61). Supernatants and cells
were collected at different time points postinfection.
The titers of delNS1 virus were detected by real-time
PCR in MDCK cells transfected with NRAS (K61).
These analyses showed that delNS1 virus had a great
increase in transfected NRAS (K61) cells than not at 36
h p.i (p < 0.05). But the replication of the delNS1 virus
was not obvious difference at 12 h p.i. and 24 h p.i.
whether transfected NRAS (K61) or not (Figure 3A).
IFN-beta and IRF-3 was also determined by the same
way. At 12 h or 24 h p.i., there was no significant differ-
ence in the levels of IFN-beta and IRF-3 between trans-
fected NRAS (K61) cells and the mock. The expression
of IFN-beta and IRF-3, compared with the un-trans-
fected MDCK cells, was repressed at 36 h postinfection
of the delNS1 virus for the cells transfected NRAS (K61)
(p < 0.05) (Figure 3B and 3C).
Discussion
RAS was a member of a small GTPase superfamily,
which could regulate a series of cell proliferation and
apoptosis. In the present study, it was found that transi-
ent expression of oncogenic NRAS (K61) in MDCK cells
influenced cell morphology and cell-cell contacts, lead-
ing to the production of comet cell. However, the typical
apoptosis of the cells was not observed. It might be the
way that constitutive activation of RAS resisted cell
death with the change of cell morphology. In mouse
cells, a transient increase in the cytoplasmic level of
oncogenic H-Ras (H-Ras (V12)) led to disintegrate of E-
cadherin complexes and activated of beta-catenin-
dependent transcription in gene reporter assays [14].
RAS was activated in host, favorably for variety viral
infection. In the HIV-1 model, downstream signaling
pathways of RAS activation was beneficial to viral repli-
cation [15]. Similarly, some other viruses also interacted
with RAS, such as influenza virus (delNS1 strain), hepa-
titis B virus, reovirus, vesicular stomatitis virus (VSV)
and adenovirus (VAI mutant) [10,16-19]. Activated RAS
was participated in different signaling pathway and exer-
cised multiple functions in various virus proliferations.
In the activated form of RAS, it was shown an increase
of the HBV X protein. In addition, activation of the
RAS signal transduction pathway could enhance the
central transcription facto r ,T B P ,a n dt h ei n d u c eo f
RNA pol III-dependent gene activity in Hepatitis B
Virus infected cells, which increased the viral replication
[16]. Cells with an activated RAS/RAF/MEK signaling
cascade allowed propagation of viruses in the presence
of IFN. Vesicular stomatitis virus (VSV) or an IFN-sen-
sitive vaccinia virus (delE3L) infected RAS-transformed
(RasV12) cells in the presence of alpha interferon, both
of which were found to similarly flourish in cells regard-
less of the presence of IFN [20]. In this study, it was
observed prominent increase of delNS1 virus in the cell
of activated NRAS (K61), which meant effective replica-
tion of delNS1 virus.
In the present study, the delNS1 H5N1 influenza
viruses with the deletion of eIF4GI binding domain dis-
played attenuated virulence in MDCK cells. In addition,
this delNS1 H5N1 strain could stimulate strong response
of IFN. DelNS1 virus lacking eIF4GI binding domain was
weak multiplication in MDCK cells because of omnipre-
sent dsRNA-dependent protein kinase (PKR) inducing
antivirus action or unable preferential translation viral
mRNA [21,22]. Recent studies were shown that the NS1
protein of influenza A virus was a major force to
Figure 2 Cells transfected with NRAS (K61) were not resulted in apoptosis. After 36 h of transfection with NRAS (K61), MDCK was changed
into comet cells. Cell death detection kit for immunohistochemical detection and quantification of apoptosis at single cell level, based on
labeling of DNA strand breaks (TUNEL technology): analysis by light microscopy. In positive control, cells were incubated with DNase I
recombinant for 10 min to induce DNA strand breaks. Arrow tip marked the apoptosis cells. For the NRAS (K61) transfected cells, there were no
bright brown particles.
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defense genes, including IFN-beta [11,12,23,24]. IRF-3, as
a transcription factor required for the induction of IFN-
beta, also could be inhibited by NS1 protein [23,25-28].
In current study, growth of delNS1 virus was depen-
dent on expression of NRAS (K61) in MDCK cells. And
it was shown that activated RAS down-regulated IFN-
induced antiviral responses. It was demonstrated that
activated RAS had been entangled in the negative regu-
lation of the IFN response. Previous study showed that
the active K-RAS restrained the IFN-gamma-activated
sequence-mediated transcription of IFN-gamma in
human cancer cells [29]. And viral oncogene (v-RAS)
was transfected in BALB/c-3T3 cells leading to inhibi-
tion of induction of MHC I by IFN-alpha [30]. Some
other studies also reported that the suppression of the
IFN response by activated RAS could be a common
mechanism which was exploited by some oncolytic
viruses. This effect was mediated at least in part by the
ability of the RAS/ERK signaling pathway to inhibit acti-
vation of IRF-3 [18]. IRF-1, initially described as a
transactivator of the IFN-beta gene, was deregulated in
RAS-transformed mouse fibroblasts (RS485) [31-33].
The cellular activity of the RAS/MEK pathway might
influence cellular susceptibility to IFN and be the mak-
ing of host susceptibility to virus [34].
Conclusions
In conclusion, this study demonstrated that activated
RAS could help defective influenza virus propagation. It
is speculated that constitutive activation of RAS inhib-
ited IFN antivirus defenses and afforded more favorable
environment for replication of delNS1 influenza virus.
The virus-infected RAS activated cells were affected by
the IFN in a complicated way, suggesting that RAS
played a significant role in virus infection, preserving
the cells, cell transformation and so on. The mode of
action of RAS needs further research.
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